AT1 receptor and HMG-CoA reductase — Drug Target

All drugs that target AT1 receptor and HMG-CoA reductase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Angiotensin II receptor antagonist and statin

Phase 3 pipeline (1)

• Valsartan and simvastatin · Novartis · Angiotensin II receptor antagonist and statin · Cardiovascular
  Valsartan is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure. Simvastatin is a statin that inhibits HMG-CoA reductase to reduce cholesterol production in the liver.